Drug Shortage Report for APO-ALENDRONATE/VITAMIN D3
Report ID | 169519 |
Drug Identification Number | 02454467 |
Brand name | APO-ALENDRONATE/VITAMIN D3 |
Common or Proper name | ALENDRONATE/D3 |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN D3 ALENDRONIC ACID |
Strength(s) | 2800UNIT 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 BLS |
ATC code | M05BB |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-13 |
Estimated end date | 2022-10-07 |
Actual end date | 2022-10-06 |
Shortage status | Resolved |
Updated date | 2022-10-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-10-07 | French | Compare |
v5 | 2022-10-07 | English | Compare |
v4 | 2022-09-30 | French | Compare |
v3 | 2022-09-30 | English | Compare |
v2 | 2022-09-16 | French | Compare |
v1 | 2022-09-16 | English | Compare |
Showing 1 to 6 of 6